Difference between revisions of "Neutropenia & leukopenia"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer. If this is your first time visiting, we suggest you read the tutorial.'''" to "<!--'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer. If this is your first time visiting, we suggest you read the tutorial.'''-->") |
Warner-admin (talk | contribs) m (Text replacement - "http://www.ncbi.nlm.nih.gov/pmc" to "https://www.ncbi.nlm.nih.gov/pmc") |
||
| (5 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
| − | + | =Guidelines= | |
| + | '''Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only.''' | ||
| + | ==ASCO== | ||
| + | *'''2023:''' Lehrnbecher et al. [https://www.ncbi.nlm.nih.gov/pmc/articles/pmc10022858/ Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update] [https://pubmed.ncbi.nlm.nih.gov/36689694/ PubMed] | ||
| + | **'''2017:''' Lehrnbecher et al. [https://doi.org/10.1200/jco.2016.71.7017 Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update] [https://pubmed.ncbi.nlm.nih.gov/28459614/ PubMed] | ||
| + | **'''2012:''' Lehrnbecher et al. [https://doi.org/10.1200/jco.2012.42.7161 Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation] [https://pubmed.ncbi.nlm.nih.gov/22987086/ PubMed] | ||
| − | ==Definition | + | ==NCCN== |
| + | *'''2004:''' Freifeld et al. [https://doi.org/10.6004/Jnccn.2004.0033 Fever and neutropenia clinical practice guidelines.] [https://pubmed.ncbi.nlm.nih.gov/19780251/ PubMed] | ||
| + | |||
| + | =Definition= | ||
*Mild neutropenia: ANC (absolute neutrophil count) 1000 to 1500 cells/uL | *Mild neutropenia: ANC (absolute neutrophil count) 1000 to 1500 cells/uL | ||
*Moderate neutropenia: ANC 500 to <1000 cells/uL | *Moderate neutropenia: ANC 500 to <1000 cells/uL | ||
*Severe neutropenia: ANC <500 cells/uL | *Severe neutropenia: ANC <500 cells/uL | ||
| − | + | =Evaluation= | |
May consist of: | May consist of: | ||
*CBC with differential | *CBC with differential | ||
| Line 27: | Line 35: | ||
[[Category:Hematology reference pages]] | [[Category:Hematology reference pages]] | ||
| + | [[Category:Supportive oncology]] | ||
Latest revision as of 12:21, 23 June 2024
Guidelines
Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only.
ASCO
- 2023: Lehrnbecher et al. Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update PubMed
- 2017: Lehrnbecher et al. Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update PubMed
- 2012: Lehrnbecher et al. Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation PubMed
NCCN
- 2004: Freifeld et al. Fever and neutropenia clinical practice guidelines. PubMed
Definition
- Mild neutropenia: ANC (absolute neutrophil count) 1000 to 1500 cells/uL
- Moderate neutropenia: ANC 500 to <1000 cells/uL
- Severe neutropenia: ANC <500 cells/uL
Evaluation
May consist of:
- CBC with differential
- Basic metabolic panel (BMP)
- Reticulocyte count
- Vitamin B12
- Folic acid
- Copper
- Urinalysis
- LDH
- Uric acid
- C3, C4
- ANA, anti-DNA antibody
- Peripheral blood flow cytometry
- Peripheral smear
- Clinical/infection history, autoimmune/rheumatologic disease, lifestyle factors (e.g. alcohol)
- Medications
- Check for splenomegaly and lymphadenopathy
- Bone marrow biopsy